RVMD · Revolution Medicines, Inc.
$203.71
+1.71 (+0.85%)
At close · Aug 14
Market Cap
$43.66B
Shares
214.34M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding RVMD
462 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 5,982,719 | $581,819,423 | 0.03% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 4,341,039 | $422,166,043 | 0.26% | Long | 2026-03-31 | |
| Fidelity Growth Company Fund | — | 2,475,942 | $389,911,346 | 0.39% | Long | 2026-05-31 | |
| Growth Fund of America | — | 1,838,422 | $289,514,697 | 0.08% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE FUND | — | 1,838,404 | $264,950,784 | 0.72% | Long | 2026-04-30 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 2,428,562 | $236,177,655 | 0.61% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 2,028,710 | $197,292,048 | 0.24% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 1,011,551 | $159,299,051 | 0.37% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | — | 942,767 | $148,466,947 | 0.65% | Long | 2026-05-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 1,519,722 | $147,792,965 | 1.36% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 1,283,912 | $124,860,442 | 1.54% | Long | 2026-03-31 | |
| Fidelity Growth Company K6 Fund | — | 682,871 | $107,538,525 | 0.39% | Long | 2026-05-31 | |
| Select Biotechnology Portfolio | — | 675,072 | $106,310,339 | 2.02% | Long | 2026-05-31 | |
| Janus Henderson Global Life Sciences Fund | — | 1,088,018 | $105,809,751 | 2.04% | Long | 2026-03-31 | |
| MFS Mid Cap Growth Fund | — | 654,055 | $103,000,581 | 0.75% | Long | 2026-05-31 | |
| Janus Henderson Enterprise Fund | — | 999,703 | $97,221,117 | 0.48% | Long | 2026-03-31 | |
| Fidelity Mid Cap Index Fund | — | 664,483 | $95,765,290 | 0.19% | Long | 2026-04-30 | |
| Fidelity Series Growth Company Fund | — | 576,602 | $90,803,283 | 0.37% | Long | 2026-05-31 | |
| Schwab U.S. Mid-Cap ETF | — | 530,570 | $83,554,164 | 0.57% | Long | 2026-05-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 850,768 | $82,737,188 | 1.11% | Long | 2026-03-31 | |
| VANGUARD EXPLORER FUND | — | 534,794 | $77,074,511 | 0.35% | Long | 2026-04-30 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 485,701 | $76,488,193 | 0.40% | Long | 2026-05-31 | |
| Lord Abbett Growth Leaders Fund | — | 526,650 | $75,900,798 | 1.00% | Long | 2026-04-30 | |
| iShares Russell Mid-Cap ETF | — | 648,760 | $63,091,910 | 0.13% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 370,778 | $58,390,119 | 0.04% | Long | 2026-05-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 361,340 | $56,903,823 | 0.96% | Long | 2026-05-29 | |
| Select Health Care Portfolio | — | 350,000 | $55,118,000 | 0.95% | Long | 2026-05-31 | |
| Janus Henderson Triton Fund | — | 554,682 | $53,942,825 | 1.04% | Long | 2026-03-31 | |
| Janus Henderson Research Fund | — | 502,273 | $48,846,049 | 0.20% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 299,436 | $47,155,181 | 0.04% | Long | 2026-05-31 | |
| Fidelity Advisor Biotechnology Fund | — | 299,500 | $43,163,940 | 2.27% | Long | 2026-04-30 | |
| iShares Russell 1000 Value ETF | — | 390,206 | $37,947,534 | 0.05% | Long | 2026-03-31 | |
| Columbia Cornerstone Growth Fund | — | 255,336 | $36,799,024 | 0.57% | Long | 2026-04-30 | |
| Janus Henderson Venture Fund | — | 371,147 | $36,094,046 | 1.18% | Long | 2026-03-31 | |
| Dimensional U.S. Core Equity 2 ETF | — | 240,648 | $34,682,190 | 0.08% | Long | 2026-04-30 | |
| Small Cap Growth Fund | — | 233,284 | $33,620,890 | 0.66% | Long | 2026-04-30 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 329,504 | $32,044,264 | 0.25% | Long | 2026-03-31 | |
| Franklin Biotechnology Discovery Fund | — | 202,430 | $29,174,212 | 2.82% | Long | 2026-04-30 | |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | — | 297,400 | $28,922,150 | 0.13% | Long | 2026-03-31 | |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund | — | 268,963 | $26,156,652 | 0.32% | Long | 2026-03-31 | |
| Eventide Healthcare & Life Sciences Fund | — | 257,218 | $25,014,451 | 1.58% | Long | 2026-03-31 | |
| Franklin Dynatech Fund | — | 250,000 | $24,312,500 | 0.10% | Long | 2026-03-31 | |
| iShares Russell Mid-Cap Value ETF | — | 244,314 | $23,759,537 | 0.17% | Long | 2026-03-31 | |
| Janus Henderson Contrarian Fund | — | 232,000 | $22,562,000 | 0.53% | Long | 2026-03-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 231,188 | $22,483,033 | 0.03% | Long | 2026-03-31 | |
| Victory Science & Technology Fund | — | 152,378 | $21,960,717 | 1.56% | Long | 2026-04-30 | |
| Marsico Midcap Growth Focus Fund | — | 219,460 | $21,342,485 | 3.22% | Long | 2026-03-31 | |
| VANGUARD TOTAL WORLD STOCK INDEX FUND | — | 144,911 | $20,884,573 | 0.02% | Long | 2026-04-30 | |
| Nuveen Equity Index Fund | — | 143,138 | $20,629,049 | 0.04% | Long | 2026-04-30 | |
| Fidelity OTC Portfolio | — | 133,478 | $19,236,849 | 0.05% | Long | 2026-04-30 |
Showing 1–50 of 462 positions
Key facts
CIK
1628171
CUSIP
76155X100
13F (30d)
642 filings
634 filers
Visit website
Investor relations